Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Büchser

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Urology|February 21, 2019
author replyD Büchser, A Zapatero, R Arellano
Clinical and Translational Radiation Oncology|February 7, 2024
Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalitiesA Gomez-Iturriaga, D Büchser, F Lopez-Campos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 18, 2018
Impact of rectum and bladder anatomy in intrafractional prostate motion during hypofractionated radiation therapyM Roch, A Zapatero, P Castro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 5, 2017
Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancerA Zapatero, M Roch, D Büchser, et al.
Clinical and Translational Radiation Oncology|September 3, 2020
MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?A Gomez-Iturriaga, D Büchser, I San Miguel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 23, 2023
Prospective study of HDR brachytherapy (BT), external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT): 10-years experience of an MRI-guided approachA Gomez-Iturriaga, L Zaragoza, I Valverde, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Urology|February 21, 2019
author replyD Büchser, A Zapatero, R Arellano
Clinical and Translational Radiation Oncology|February 7, 2024
Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalitiesA Gomez-Iturriaga, D Büchser, F Lopez-Campos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 18, 2018
Impact of rectum and bladder anatomy in intrafractional prostate motion during hypofractionated radiation therapyM Roch, A Zapatero, P Castro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 5, 2017
Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancerA Zapatero, M Roch, D Büchser, et al.
Clinical and Translational Radiation Oncology|September 3, 2020
MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?A Gomez-Iturriaga, D Büchser, I San Miguel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 23, 2023
Prospective study of HDR brachytherapy (BT), external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT): 10-years experience of an MRI-guided approachA Gomez-Iturriaga, L Zaragoza, I Valverde, et al.
Pageof 1